Prognosis depends on the subtype, the staging, a person's age, and other factors. Across all subtypes, 5-year survival for<unk>  is 71%, ranging from 81% for Stage 1 disease to 61% for Stage 4 disease.
Non-Hodgkin lymphoma
Monoclonal gammopathy of renal significance  Monoclonal gammopathy of renal significance  1
B-cell lymphoma
Aggressive lymphoma
AIDS-related lymphoma
Burkitt lymphoma
T-cell lymphoma
Mixed-cell lymphoma